NASA has successfully launched Cygnus Cargo Ship which is now heading toward the International Space Station and will rash there on 14th November. This is a resupply mission of NASA and carrying some important equipment and projects for the scientists.
As per the report, the spacecraft is also carrying the E.coli AntiMicrobial Satellite (EcAMSat). It was developed By NASA’s Ames Research Centre with the help of the Stanford University of Medicine. EcAMSat weighs around 23 pounds and measures around 14.4 inches long, 8.9 inches wide and 3.9 inches tall. The mission is funded as part of the Space Biology Project at NASA Ames Research Center.
As per the statement given by NASA, “the EcAMSat mission will investigate space microgravity effects on the antibiotic resistance of E. coli, a bacterial pathogen responsible for urinary tract infection in humans and animals.”
As per the report, it will conduct research spaceflight effects on bacterial antibiotic resistance and its genetic basis. It is believed that, after the study, the result will give sufficient data to develop effective measures which will protect the astronaut’s health while going on the human space mission. On Earth, medical researchers will also be able to understand the bacteria’s response to stress and they can develop perfect antibiotics.
“The experiment will determine the lowest concentration of antibiotic that inhibits bacterial growth. The knowledge gained in this experiment may be used for prescribing the correct dose of antibiotics for future space travelers,” the statement informed. It further stated that “EcAMSat will utilize flight-proven spacecraft technologies demonstrated on prior Ames nanosatellite missions such as PharmaSat and Organism/Organic Exposure to Orbital Stresses.”
“The overall purpose of this is to challenge these bacteria to different stress levels that will be controlled autonomously through software,” said Stevan Spremo, the EcAMSat project manager at NASA’s Ames Research Center in Silicon Valley, California.